This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CareFusion Announces Agreement To Resell Codonics Technology To Enhance Safety And Compliance In The Operating Room

SAN DIEGO, June 6, 2012 /PRNewswire/ --  CareFusion today announced it has signed an agreement with Codonics, a global leader in image documentation and medication safety systems, to resell the Codonics Safe Label System SLS 500i with the Pyxis® Anesthesia System 3500, enhancing CareFusion's leading system for simplifying and improving the availability, storage and documentation of OR medications.

"Hospitals are under enormous pressure to improve medication safety and become more efficient in managing medication throughout their facilities—from the pharmacy to the patient," said Rusty Frantz, senior vice president and general manager of Dispensing Technologies at CareFusion. "The Pyxis Anesthesia System provides secure, convenient and traceable access to controlled substances, helping health care providers streamline workflow and pharmacy operations. By offering the Safe Label System from Codonics with our solution, our customers will be better positioned to address critical medication safety guidelines and further improve clinical efficiency."

The Pyxis Anesthesia System is a secure medication management system that helps ensure access to and traceability of controlled substances in the operating room. The Codonics Safe Label System SLS 500i is a first-of-its-kind FDA-Class II medical device that provides safe, compliant labeling of medication in the OR or anywhere syringes are prepared. The Safe Label System improves medication safety, efficiency and accuracy, applying leading technologies to help reduce drug errors.When combined, the offering helps hospitals address important medication safety guidelines in the perioperative environment by helping clinicians ensure syringe labels comply with the National Patient Safety Goals of The Joint Commission Standards and the American Society of Anesthesiologists (ASA) Guidelines for medication labeling. Both systems help eliminate time-consuming manual processes and complement the workflow of anesthesiologists.

"In a short time since implementing the Pyxis Anesthesia System and the Codonics Safe Label System, our clinicians have reported numerous safety and workflow enhancements," said Sal Morana, RPh, PhD, director of pharmacy and associate vice president of patient care services at Porter Medical Center in Middlebury, Vt. "Among them, we have experienced less variability in the medication administration process and enhanced verification methods , which have helped prevent dosage errors."

"We are excited to partner with CareFusion to enhance medication safety," said Peter O. Botten, president and CEO of Codonics. "The Safe Label System brings pharmacy control into the OR to help ensure that patients are treated with the right drug and the right concentration, with barcode technology to improve the syringe preparation workflow. The Safe Label System complements the Pyxis Anesthesia System and acts as an electronic double-check, bringing all of the best practices for medication safety together to support guidance-driven compliance while enhancing medication safety and clinical workflow."

About CareFusionCareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, Air Life™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at


SOURCE CareFusion

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs